The preventive potential of milk and colostrum proteins and protein fragments

Food Reviews International

Volumn 27, Issue 4, 2011, Pages 357-388

  Darewicz, Malgorzata ^a   Dziuba, Bartlomiej ^a   Minkiewicz, Piotr ^a   Dziuba, Jerzy ^a  

^a UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

Author keywords

Biological activity; Colostrum; Disease; Milk; Peptides; Preventive potential; Proteins

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 79960372598     PISSN: 87559129     EISSN: 15256103     Source Type: Journal    
DOI: 10.1080/87559129.2011.563396     Document Type: Article

References (279)

1. Kelly, G.S. Bovine colostrums: a review of clinical uses. Alternative Medicine Review 2003, 8, 378-394.
2. Fox, P.F.; McSweeney, P.L.H. Dairy Chemistry and Biochemistry; Chapman & Hall: London, 1998.
3. Wong, D.W.S.; Camirand, W.M.; Pavlath, A.E. Structures and functionalities of milk proteins. Critical Reviews in Food Science Nutrition 1996, 36, 807-844.
4. Kilara, A.; Panyam, D. Peptides from milk proteins and their properties. Critical Reviews in Food Science Nutrition 2003, 43, 607-633.
5. Potier, M.; Tomé, D. Comparison of digestibility and quality of intact proteins with their respective hydrolysates. Journal of AOAC International 2008, 91, 1002-1005.
6. Monaci, L.; Tregoat, V.; van Hengel, A.J.; Anklam, E. Milk allergens; their characteristics and their detection in food: a review. European Food Research and Technology 2006, 223, 149-179.
7. Brill, H. Approach to milk protein allergy in infants. Canadian Family Physician 2008, 54, 1258-1264.
8. Houdebine, L.-M. Production of pharmaceutical proteins by transgenic animals. Comparative Immunology. Microbiology and Infectious Diseases 2009, 32, 107-121.
9. Latham, P.W. Therapeutic peptides revisited. Nature Biotechnology 1999, 17, 755-758.
10. Arai, S.; Osawa, T.; Ohigashi, H.; Yoshikawa, M.; Kaminogawa, S.; Watanabe, M.; Ogawa, T.; Okubo, K.; Watanabe, S.; Nishino, H.; Shinohara, K.; Esashi, T.; Hirahara, T. A mainstay of functional food science in Japan-history, present status and future outlook. Bioscience, Biotechnology and Biochemistry 2001, 65, 1-13.
11. Pillarisetti, S. Are peptide therapeutics the future? Current Pharmaceutical Biotechnology 2006, 7, 225-227.
12. Schlimme, E.; Meisel, H. Bioactive peptides derived from milk proteins. Structural, physiological and analytical aspects. Nahrung 1995, 39, 1-20.
13. Karelin, A.A.; Blischenko, E.Y.; Ivanov, V.T. A novel system of peptidergic regulation. FEBS Letters 1998, 428, 7-12.
14. Autelitano, D.J.; Rajic, A.; Smith, A.I.; Berndt, M.C.; Ilag, L.L.; Vadas, M. The cryptome: a subset of the proteome, comprising cryptic peptides with distinct bioactivities. Drug Discovery Today 2006, 11, 306-314.
15. Pimenta, D.C.; Lebrun, I. Cryptides: buried secrets in proteins. Peptides 2007, 28, 2403-2410.
16. Minkiewicz, P.; Dziuba, J.; Darewicz, M.; Iwaniak, A.; Dziuba, M.; Nałe{ogonek}cz, D. Food peptidomics. Food Technology and Biotechnology 2008, 46, 1-10.
17. Smacchi, E.; Gobbetti, M. Bioactive peptides in dairy products: synthesis and interaction with proteolytic enzymes. Food Microbiology 2000, 17, 129-141.
18. Kitts, D.D.; Weiler, K. Bioactive proteins and peptides from food sources. Application of bioprocesses used in isolation and recovery. Current Pharmaceutical Design 2003, 9, 1309-1323.
19. Korhonen, H.; Pihlanto, A. Food-derived bioactive peptides-opportunities for designing future foods. Current Pharmaceutical Design 2003, 9, 1297-1308.
20. Thomä-Worringer, C.; Sørensen, J.; López-Fandiño, R. Health effects and technological features of caseinomacropeptide. International Dairy Journal 2006, 16, 1324-1333.
21. Korhonen, H.; Pihlanto, A. Bioactive peptides: production and functionality. International Dairy Journal 2006, 16, 945-960.
22. FitzGerald, R.J.; Meisel, H. Milk proteins hydrolysates and bioactive peptides. In Advanced Dairy Chemistry. Proteins, 3rd ed.; Ed: Fox, P.F.; McSweeney, P.L.H.; Kluwer Academic/Plenum Publishers:, New York, 2003; 675-698.
23. Korhonen, H.; Pihlanto, A. Technological options for the production of health-promoting proteins and peptides derived from milk and colostrums. Current Pharmaceutical Design 2007, 13, 829-843.
24. Korhonen, H.; Pihlanto-Leppälä, A. Milk-derived bioactive peptides: formation and prospects for health promotion. In Handbook of Functional Dairy Products. Functional Foods and Nutraceuticals; Ed: Shortt, C.: O'Brien, J.; CRC Press: Boca Raton, FL, 2004; 109-124.
25. Meisel, H. Multifunctional peptides encrypted in milk proteins. BioFactors 2004, 21, 55-61.
26. Cross, K.J.; Huq, N.L.; Reynolds, E.C. Casein phosphopeptides in oral health-chemistry and clinical applications. Current Pharmaceutical Design 2007, 13, 793-800.
27. Murray, B.A.; FitzGerald, R.J. Angiotensin converting enzyme inhibitory peptides derived from food proteins: biochemistry, bioactivity and production. Current Pharmaceutical Design 2007, 13, 773-791.
28. Parodi, P.W. A role for milk proteins and their peptides in cancer prevention. Current Pharmaceutical Design 2007, 13, 813-828.
29. Hartmann, R.; Meisel, H. Food-derived peptides with biological activity: from research to food applications. Current Opinion in Biotechnology 2007, 18, 163-169.
30. Zimecki. M.; Kruzel, M.L. Milk-derived proteins and peptides of potential therapeutic and nutritive value. Journal of Experimental Therapeutics and Oncology 2007, 6, 89-106.
31. Shahidi, F.; Zhong, Y. Bioactive peptides. Journal of AOAC International 2008, 91, 914-931.
32. Haque, E.; Chand, R.; Kapila, S. Biofunctional properties of bioactive peptides of milk origin. Food Reviews International 2009, 25, 28-43.
33. Gobbetti, M; Stepaniak, L.; De Angelis, M.; Corsetti, A.; Di Cagno, R. Latent bioactive peptides in milk proteins: proteolytic activation and significance in dairy processing. Critical Reviews in Food Science and Nutrition 2002, 42, 223-239.
34. Gobbetti, M.; Minervini, F.; Rizzello, C. Angiotensin I-converting-enzyme-inhibitory and antimicrobial peptides. International Journal Dairy Technology 2004, 57, 172-188.
35. Korhonen, H.; Pihlanto-Leppälä, A. Milk protein-derived bioactive peptides-novel opportunities for health promotion. Bulletin of the IDF 2001, 363, 17-26.
36. Matar, C.; LeBlanc, J.G.; Martin, L.; Perdigón, G. Biologically active peptides released in fermented milk: role and functions. In Handbook of Fermented Functional Foods. Functional Foods and Nutraceutical Series; Ed: Farnworth, T.; CRC Press: Boca Raton, FL, 2003; 177-201.
37. Bütikofer, U.; Meyer, J.; Sieber, R.; Wlather, B.; Wechsler, D. Occurrence of the angiotensinconverting enzyme-inhibiting tripeptides Val-Pro-Pro and Ile-Pro-Pro in different cheese varieties of Swiss origin. Journal of Dairy Science 2008, 91, 29-38.
38. Seppo, L.; Jauhiainen, T.; Poussa, T.; Korpela, R. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. American Journal of Clinical Nutrition 2003, 77, 326-330.
39. Ganalpathy, V.; Leibach, F.H. Protein digestion and assimilation. In Textbook of Gastroenterology; Ed: Yamada, T.; Lippincott, Williams & Wilkins: Philadelphia, 1999; 456-467.
40. Kostyra, E.; Sienkiewicz-Szłapka, E.; Jarmołowska, B.; Krawczuk, S.; Kostyra, H. Opioid peptides derived from milk proteins. Polish Journal of Food and Nutrition Sciences 2004, 13, 25-35.
41. Pauletti, G.M.; Gangwar, S.; Knipp, G.T.; Nerurkar, M.M.; Okumu, F.W.; Tamura, K.; Siahaan, T.J.; Borchardt, R.T. Structural requirements for intestinal absorption of peptide drugs. Journal of Controlled Release 1996, 41, 3-17.
42. Ganapathy, V.; Miyauchi, S. Transport systems for opioid peptides in mammalian tissues. The AAPS Journal 2005, 7, 852-885.
43. Yang, C.Y.; Dantzig, A.H.; Pidgeon, C. Intestinal peptide transport systems and oral drug availability. Pharmaceutical Research 1999, 16, 1331-1343.
44. Salamat-Miller, N.; Johnston, T.P. Current strategies used to enhance the paracellular transport of therapeutic polypeptides across the intestinal epithelium. International Journal of Pharmaceutics 2005, 294, 201-216.
45. Knip, G.T.; Vander Velde, D.G.; Siahaan, T.J.; Borchardt, R.T. The effect of β-turn structure on the passive diffusion of peptides across Caco-2 cells monolayers. Pharmaceutical Research 1997, 14, 1332-1341.
46. Roberts, P.R.; Burney, J.D.; Black, K.W.; Zaloga, G.P. Effect of chain length on adsorption of biologically active peptides from the gastrointestinal tract. Digestion 1999, 60, 332-337.
47. Picariello, G.; Ferranti, P.; Fiero, O.; Mamone, G.; Caira, S.; Di Lucia, A.; Monica, S.; Addeo, F. Peptides surviving the simulated gastrointestinal digestion of milk proteins: biological and toxicological implications. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 2010, 878, 295-308.
48. Quirós, A.; Daválos, A.; Lasunción, M.A.; Ramos, M.; Recio, I. Bioavailability of antihypertensive peptide LHLPLP. Transphithelial flux of HLPLP. International Dairy Journal 2008, 18, 279-286.
49. Antosova, Z.; Mackova, M.; Kral, V.; Macek, T. Therapeutic application of peptides and proteins: parenteral forever? Trends in Biotechnology 2009, 27, 628-635.
50. Jauhiainen, T.; Korpela, R.; Vapaatalo, H.; Turpeinen, A.M.; Kautiainen, H. Bioactive milk proteins and blood pressure. Agro Food Industry Hi-Tech 2009, 20, 26-28.
51. Pripp, A.H. Effect of peptides derived from food proteins on blood pressure: a metaanalysis of randomized controlled trials. Food and Nutrition Research 2008, 52.
52. Jelić, D.; Toth, D.; Verbanac, D. Macromolecular databases-a background of bioinformatics. Food Technology and Biotechnology 2003, 41, 269-286.
53. Akalin, P.K. Introduction to bioinformatics. Molecular Nutrition and Food Research 2006, 50, 610-619.
54. Minkiewicz, P.; Dziuba, J.; Iwaniak, A.; Dziuba, M.; Darewicz, M. BIOPEP database and other programs for processing bioactive peptide sequences. Journal of AOAC International 2008, 91, 965-980.
55. Boonen, K.; Landuyt, B.; Baggerman, G.; Husson, S.J.; Huybrechts, J.; Schoofs, L. Peptidomics: the integrated approach of MS, hyphenated techniques and bioinformatics for neuropeptide analysis. Journal of Separation Science 2008, 31, 427-445.
56. Minkiewicz, P.; Dziuba, J.; Darewicz, M.; Iwaniak, A.; Michalska, J. Online programs and databases of peptides and proteolytic enzymes-a brief update for 2007-2008. Food Technology and Biotechnology 2009, 47, 345-355.
57. Jain, E.; Bairoch, A.; Duvaud, S.; Phan, I.; Redaschi, N.; Suzek, B.E., Martin, M.J.; McGarvey, P.; Gasteiger, E. Infrastructure for the life sciences: design and implementation of the UniProt website. BMC Bioinformatics 2009, 10, Art. No. 136.
58. The UniProt Consortium. The Universal Protein Resource (UniProt) in 2010. Nucleic Acids Research 2010, 38, D142-D148.
59. Sayers, E.W.; Barrett, T.; Benson, D.A.; Bryant S.H.; Canese, K.; Chetvernin, V.; Church, D.M.; DiCuccio, M.; Edgar, R.; Federhen, S.; Feolo, M.; Geer, L.Y.; Helmberg, W.; Kapustin, Y.; Landsman, D.; Lipman, D.J.; Madden, T.L.; Maglott, D.R., Miller, V., Mizrachi, I.; Ostell, J.; Pruitt K.D.; Schuler G.D.; Sequeira, E.; Sherry, S.T.; Shumway, M.; Sirotkin, K.; Souvorov, A.; Starchenko, G.; Tatusova, T.A.; Wagner, L.; Yaschenko, E.; Ye, J. Database resources of the National Center for Biotechnology Information. Nucleic Acids Research 2009, 37, D5-D15.
60. Benson, D.A.; Karsch-Mizrachi, I.; Lipman, D.J.; Ostell, J.; Sayers, E.W. GenBank. Nucleic Acids Research 2010, 38, D46-D51.
61. Berman, H.; Henrick, K.; Nakamura, H.; Markley, J.L. The worldwide Protein Data Bank (wwPDB): ensuring a single, uniform archive of PDB data. Nucleic Acids Research 2007, 35, D301-D303.
62. Dutta, S.; Burkhardt, K.; Young, J.; Swaminathan, G.J.; Matsuura, T.; Henrick, K.; Nakamura, H.; Berman, H.M. Data deposition and annotation at the worldwide Protein Data Bank. Molecular Biotechnology 2009, 42, 1-13.
63. Brusic, V. Information management for the study of allergies. Inflammation & Allergy-Drug Targets 2006, 5, 35-42.
64. Gendel, S.M. Allergen databases and allergen semantics. Regulatory Toxicology and Pharmacology 2009, 54(3 Suppl.), S7-S10.
65. Korber, B.; LaBute, M.; Yusim, K. Immunoinformatics comes of age. PLoS Computational Biology 2006, 2, 484-492.
66. Tong, J.C.; Ren, E.C. Immunoinformatics: current trends and future directions. Drug Discovery Today 2009, 14, 684-689.
67. Dziuba, J.; Iwaniak, A. Database of protein and bioactive peptide sequences. In Nutraceutical Proteins and Peptides in Health and Disease; Ed: Minc, Y.; Shahidi, F.; CRC: Boca Raton, FL, 2006; 543-563.
68. Zamyatnin, A.A.; Borchikov, A.S.; Vladimirov, M.G.; Voronina, O.L. The EROP-Moscow oligopeptide database. Nucleic Acids Research 2006, 34, D261-D266.
69. Shtatland, T.; Guettler, D.; Kossodo, M.; Pivovarov, M.; Weissleder, R. PepBank-a database of peptides based on sequence text mining and public peptide data sources. BMC Bioinformatics 2007, 8, Art. No. 280.
70. Duchrow, T.; Shtatland, T.; Guettler, D.; Pivovarov, M.; Kramer, S.; Weissleder, R. Enhancing navigation in biomedical databases by community voting and database-driven text classification. BMC Bioinformatics 2009, 10, Art. No. 317.
71. Dziuba, J.; Niklewicz M.; Iwaniak, A.; Darewicz M.; Minkiewicz, P. Structural properties of proteolytic accessible bioactive fragments of selected animal proteins. Polimery 2005, 50, 424-428.
72. Dziuba, M.; Darewicz, M. Food proteins as precursors of bioactive peptides-division into families. Food Science and Technology International 2007, 13, 393-404.
73. Dziuba, M.; Dziuba, B.; Iwaniak, A. Milk proteins as precursors of bioactive peptides. Acta Scientiarum Polonorum Technologia Alimentaria 2009, 8(1), 71-90.
74. Weimann, C.; Meisel, H.; Erhardt, G. Bovine κ-casein variants result in different angiotensin I converting enzyme (ACE) inhibitory peptides. Journal of Dairy Science 2009, 92, 1885-1888.
75. Vita, R.; Zarebski, L.; Greenbaum, J.A.; Emami, H.; Hoof, I.; Salimi, N.; Damle, R.; Sette, A.; Peters, B. The Immune Epitope Database 2.0. Nucleic Acids Research 2010, 38, D854-D862.
76. Minkiewicz, P.; Dziuba, J.; Gładkowska, I. Update of the list of allergenic proteins from milk, based on local amino acid sequence identity with known epitopes from bovine milk proteins-a short report. Polish Journal of Food and Nutrition Sciences 2011, 61, 153-158.
77. Schomburg, I.; Chang, A.; Schomburg, D. BRENDA, enzyme data and metabolic information. Nucleic Acids Research 2002, 30, 47-49.
78. Chang, A.; Scheer, M.; Grote, A.; Schomburg, I.; Schomburg, D. BRENDA, AMENDA and FRENDA the enzyme information system: new content and tools in 2009. Nucleic Acids Research 2009, 37, D588-D592.
79. McDonald, A.G.; Boyce, S.; Moss, G.P.; Dixon, H.B.F.; Tipton K.F. ExplorEnz: a MySQL database of the IUBMB enzyme nomenclature. BMC Biochemistry 2007, 8, Art. No. 14.
80. McDonald, A.G.; Boyce, S.; Tipton K. F. ExplorEnz: the primary source of the IUBMB enzyme list. Nucleic Acids Research 2009, 37, D593-D597.
81. Rawlings, N.D. A large and accurate collection of peptidase cleavages in the MEROPS database. Database 2009, 1, Art. No. bap015.
82. Rawlings, N.D.; Barrett, A.J.; Bateman, A. MEROPS: the peptidase database. Nucleic Acids Research 2010, 38, D227-D233.
83. Igarashi, Y.; Eroshkin, A.; Gramatikova, S.; Gramatikoff, K.; Zhang, Y.; Smith, J.W.; Osterman, A.L.; Godzik A. CutDB: a proteolytic event database. Nucleic Acids Research 2007, 35, D546-D549.
84. Contreras, M.D.M.; López-Expósito, I.; Hernández-Ledesma, B.; Ramos, M.; Recio, I. Application of mass spectrometry to the characterization and quantification of food-derived bioactive peptides. Journal of AOAC International 2008, 91, 981-994.
85. Forner, F.; Foster, L.J.; Toppo, S. Mass spectrometry data analysis in the proteomics era. Current Bioinformatics 2007, 2, 63-93.
86. Shinoda, K.; Sugimoto, M.; Tomita, M.; Ishihama, Y. Informatics for peptide retention properties in proteomic LC-MS. Proteomics 2008, 8, 787-798.
87. Ba{ogonek}czek, T.; Kaliszan, R. Predictions of peptides' retention times in reversed-phase liquid chromatography as a new supportive tool to improve protein identification in proteomics. Proteomics 2009, 9, 835-847.
88. Tonouchi, H.; Suzuki, M.; Uchida, M.; Oda, M. Antihypertensive effect of an angiotensin converting enzyme inhibitory peptide from enzyme modified cheese. Journal of Dairy Research 2008, 75, 284-290.
89. Miyoshi, S.; Ishikawa, H.; Kaneko, T.; Fukui, F.; Tanaka, H.; Maruyama, S. Structures and activity of angiotensin-converting enzyme inhibitors in an alpha-zein hydrolysate. Agricultural and Biological Chemistry 1991, 55, 1313-1318.
90. Dziuba, J.; Minkiewicz, P.; Nałe{ogonek}cz, D.; Iwaniak, A. Database of biologically active peptide sequences. Nahrung 1999, 43, 190-195.
91. Vermeirssen, V.; van den Bent, A.; Van Camp, J.; van Amerongen, A.; Verstraete, W. A quantitative in silico analysis calculates the angiotensin I converting enzyme (ACE) inhibitory activity in pea and whey protein digests. Biochimie 2004, 86, 231-239.
92. Vercruysse, L.; Smagghe, G.; van der Bent, A.; van Amerongen, A.; Ongenaert, M.; van Camp, J. Critical evaluation of the use of bioinformatics as a theoretical tool to find high-potential sources of ACE inhibitory peptides. Peptides 2009, 30, 575-582.
93. Jollès, P.; Lèvy-Toledano, S.; Fiat, A.-M.; Soria, C.; Gillessen, O.; Thomaidis A.; Dunn, F.W.; Caen, J.P. Analogy between fibrinogen and casein. Effect of an undecapeptide isolated from κ-casein on platelet function. European Journal of Biochemistry 1986, 158, 379-382.
94. Liu, Z.P.; Wu, L.-Y.; Wang, Y.; Zhang, X.-S.; Chen, L. Bridging protein local structures and protein functions. Amino Acids 2008, 35, 627-650.
95. Bailey, T.L.; Williams, N.; Misleh, C.; Li, W.W. MEME: discovering and analyzing DNA and protein sequence motifs. Nucleic Acids Research 2006, 34, 369-373.
96. Frith, M.C.; Saunders, N.F.W.; Kobe, B.; Bailey, T.L. Discovering sequence motifs with arbitrary insertions and deletions. PLoS Computational Biology 2008, 4, Art. No. e1000071.
97. Bailey, T.L.; Boden, M.; Buske, F.A.; Frith, M.; Grant, C.E.; Clementi, L.; Ren, J.; Li, W.W.; Noble, W.S. MEME SUITE: tools for motif discovery and searching. Nucleic Acids Research 2009, 37, W202-W208.
98. Darewicz, M.; Dziuba, J.; Minkiewicz P. Computational characterisation and identification of peptides for in silico detection of potentially celiac-toxic proteins. Food Science and Technology International 2007, 13, 125-133.
99. Shevchenko, A.; Sunyaev, S.; Loboda, A.; Shevchenko, A.; Bork, P., Ens, W.; Standing, K.G. Charting the proteomes of organisms with unsequenced genomes by MALDI-quadrupole time of flight mass spectrometry and BLAST homology searching. Analytical Chemistry 2001, 73, 1917-1926.
100. Shan, L.; Molberg, Ø.; Parrot, I.; Hausch, F; Filiz, F.; Gray, G.M.; Sollid L.M.; Khosla C. Structural basis for gluten intolerance in celiac spruce. Science 2002, 297, 2275-2279.
101. Camarca, A.; Anderson, R.P.; Mamone, G.; Fierro, O.; Facchiano, A.; Costantini, S.; Zanzi D.; Sidney, J.; Auricchio, S.; Sette, A.; Troncone, R.; Gianfrani, C. Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease. Journal of Immunology 2009, 182, 4158-4166.
102. Cabrera-Chávez, F.; Calderón de la Barca, A.M. Bovine milk intolerance in celiac disease is related to IgA reactivity to α-and β-caseins. Nutrition 2009, 25, 715-716.
103. Altschul, S.F.; Madden, T.L., Schäffer, A.A.; Zhang, J.; Zhang, Z.; Miller, W.; Lipman, D. J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Research 1997, 25, 3389-3402.
104. Pearson, W.R. Flexible sequence similarity searching with the FASTA3 program package. Methods in Molecular Biology 2000, 132, 185-219.
105. Pripp, A.H.; Isakson, T.; Stepaniak, L.; Sørhaug, T.; Ardö, Y.; Quantitative structure activity relationship modelling of peptides and proteins as a tool in food science. Trends in Food Science and Technology 2005, 16, 484-494.
106. Du, Q.-S.; Huang, R.-B.; Chou, K.-C. Recent advances in QSAR and their applications in predicting the activities of chemical molecules, peptides and proteins for drug design. Current Protein and Peptide Science 2008, 9, 248-259.
107. Scior, T.; Medina-Franco, J.L.; Do, Q.-T.; Martínez-Mayorga, K.; Yunes Rojas, J.A.; Bernard, P. How to recognize and workaround pitfalls in QSAR studies: a critical review. Current Medicinal Chemistry 2009, 16, 4297-4313.
108. Kawashima, S.; Pokarowski, P.; Pokarowska, M.; Koliński, A.; Katayama, T.; Kanehisa, M. AAindex: amino acid index database, progress report 2008. Nucleic Acids Research 2008, 36, D202-D205.
109. Pripp, A.H.; Isaksson, T.; Stepaniak, L.; Sørhaug, T. Quantitative structure activity relationship (QSAR) of ACE-inhibitory peptides derived from milk proteins. European Food Research and Technology 2004, 219, 579-583.
110. Pripp, A.H. Quantitative structure-activity relationship of prolyl oligopeptidase inhibitory peptides derived from β-casein using simple amino acid descriptors. Journal of Agricultural and Food Chemistry 2006, 54, 224-228.
111. Pripp, A.H. Initial proteolysis of milk proteins and its effect on formation of ACEinhibitory peptides during gastrointestinal proteolysis: a bioinformatic approach. European Food Research and Technology 2005, 221, 712-716.
112. Pripp, A.H.; Ardö, Y. Modelling relationship between angiotensin-(I)-converting enzyme inhibition and the bitter taste of peptides. Food Chemistry 2007, 102, 880-888.
113. Pripp, A.H. Docking and virtual screening of ACE inhibitory dipeptides. European Food Research and Technology 2007, 225, 589-592.
114. Kaczanowski, S.; Siedlecki, P.; Zielenkiewicz, P. The High Throughput Sequence Annotation Service (HT-SAS)-the shortcut from sequence to true Medline words. BMC Bioinformatics 2009, 10, Art. No. 148.
115. Tong, J.C.; Lim, S.J.; Muh, H.C.; Chew, F.T.; Tammi, M.T. Allergen atlas: a comprehensive knowledge center and analysis resource for allergen information. Bioinformatics 2009, 25, 979-980.
116. Nakamura, R.; Teshima, R.; Talagi, K.; Sawada, J.-I. Development of Allergen Database for Food Safety (ADFS): an integrated database to search allergens and predict allergenicity. Bulletin of the National Institute for Health Science 2005, 123, 32-36.
117. Mari, A.; Scala, E.; Palazzo, P.; Ridolfi, S.; Zennaro, D.; Carabella, G. Bioinformatics applied to allergy: Allergen databases, from collecting sequence information to data integration. The Allergome platform as a model. Cellular Immunology 2006, 244, 97-100.
118. Mari, A.; Rasi, C.; Palazzo, P.; Scala, E. Allergen databases: current status and perspectives. Current Allergy and Asthma Reports 2009, 9, 376-383.
119. Fiers, W.E.J.; Kleter, G.A.; Nijland, H.; Peijnenburg, A.A.C.M.; Nap, J.P.; van Ham, R.C.H.J. Allermatch™, a webtool for the prediction of potential allergenicity according to current FAO/WHO Codex Alimentarius guidelines. BMC Bioinformatics 2004, 5, Art. No. 133.
120. Ivanciuc, O.; Schein, C.H.; Garcia, T.; Oezguen, N.; Negi, S.S.; Braun, W. Structural analysis of linear and conformational epitopes of allergens. Regulatory Toxicology and Pharmacology 2009, 54(3 Suppl.), S11-S19.
121. Gasteiger, E.; Hoogland, C.; Gattiker, A.; Duvaud, S.; Wilkins, M.R.; Appel, R.D.; Bairoch, A. Protein identification and analysis tools on the ExPASy server. In The Proteomics Protocols Handbook; Walker, J.M., Ed.; Humana Press: Totowa, NJ, 2005; 571-607.
122. Combet, C.; Blanchet, C.; Geourjon, C.; Deleagé, G.: NPS@: Network Protein Sequence Analysis. Trends in Biochemical Sciences 2000, 25, 147-150.
123. Cheng, J.; Randall, A.Z.; Sweredowski, M.J.; Baldi, P. SCRATCH: a protein structure and structural feature prediction server. Nucleic Acids Research 2005, 33, W72-W77.
124. McWilliam, H.; Valentin, F.; Goujon, M.; Li, W., Narayanasamy, M.; Martin J.; Miyar, T.; Lopez, R. 2009, Web services at the European Bioinformatics Institute-2009. Nucleic Acids Research 2009, 37, W6-W10.
125. Dziuba, J.; Iwaniak, A.; Minkiewicz, P. Computer-aided characteristics of proteins as potential precursors of bioactive peptides. Polimery 2003, 48, 50-53.
126. Pihlanto, A.; Korhonen, H. Bioactive peptides and proteins. Advances in Food and Nutrition Research 2003, 47, 175-276.
127. Meisel, H.; Schlimme, E. Milk proteins: precursors of bioactive peptides. Trends in Food Science and Technology 1990, 1, 41-43.
128. Silva, S.V.; Malcata, F.X. Caseins as source of bioactive peptides. International Dairy Journal 2005, 15, 1-15.
129. Phelan, M.; Aherne-Bruce, S.A.; O'Sullivan, D.; FitzGerald, R.J.; O'Brien, N.M. Potential bioactive effects of casein hydrolysates on human cultured cells. International Dairy Journal 2009, 19, 279-285.
130. FitzGerald, R.J.; Murray, B.A.; Walsh, D.J. Hypotensive peptides from milk proteins. Journal of Nutrition 2004, 143, 980S-988S.
131. Eriksson, U.; Danilczyk, U.; Penninger, J.M. Just the beginning: novel functions for angiotensin-converting enzymes. Current Biology 2002, 12, R745-R752.
132. Santos, R.A.S.; Campagnole-Santos, M.J.; Pinheiro, S.V.B.; Ferreira, A.J. The renninangiotensin system: emerging concepts. Current Hypertension Reviews 2006, 2, 219-226.
133. Schmieder, R.E.; Hilgers, K.F.; Schlaich, M.P.; Schmidt, B.M.W. Renin-angiotensin system and cardiovascular risk. Lancet 2007, 369, 1208-1219.
134. Igic, R.; Behnia, R. Pharmacological, immunological and gene targeting of the rennin-angiotensin system for treatment of cardiovascular disease. Current Pharmaceutical Design 2007, 13, 1199-1214.
135. Heffelfinger, S.C. The renin angiotensin system in the regulation of angiogenesis. Current Pharmaceutical Design 2007, 13, 1215-1229.
136. Lazartigues, E.; Feng, Y.; Lavoie, J.L. The two fACEs of the tissue rennin-angiotensin systems: implication in cardiovascular diseases. Current Pharmaceutical Design 2007, 13, 1231-1245.
137. Kumar, R.; Singh, V.P.; Baker, K.M. The intracellular renin-angiotensin system in the heart. Current Hypertension Reports 2009, 11, 104-110.
138. Rutherfurd-Markwick, K.J.; Moughan, P.J. Bioactive peptides derived from food. Journal of AOAC International 2005, 88, 955-966.
139. Meisel, H. Biochemical properties of regulatory peptides derived from milk proteins. Biopolymers 1997, 43, 119-128.
140. Meisel, H.; Schlimme, E. Inhibitors of angiotensin-converting-enzyme derived from bovine casein (casokinins). In β-Casomorphins and Related Peptides: Recent Developments; Brantl, V.; Teschemacher, H., Eds.; VCH: Weinheim, Germany, 1994; 27-33.
141. Tonouchi, H.; Suzuki, M.; Uchida, M.; Oda, M. Antihypertensive effect of an angiotensin converting enzyme inhibitory peptide from enzyme modified cheese. Journal of Dairy Research 2008, 75, 284-290.
142. Gómez-Ruiz, J.A.; Ramos, M.; Recio, I. Angiotensin-converting enzyme-inhibitory peptides in Manchego cheeses manufactured with different starter cultures. International Dairy Journal 2002, 12, 697-706.
143. Maeno, M.; Yamamoto, N.; Takano, T. Identification of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus Cp790. Journal of Dairy Science 1996, 79, 1316-1321.
144. Nakamura, Y.; Yamamoto, N.; Sakai, K.; Okubo, A.; Yamazaki, S.; Takano, T. Purification and characterization of angiotensin-I-converting enzyme inhibitors from sour milk. Journal of Dairy Science 1995, 78, 777-783.
145. Shuangquan.; Tsuda, H.; Miyamoto, T. Angiotensin I-converting enzyme inhibitory peptides in skim milk fermented with Lactobacillus helveticus 130B4 from camel milk in Inner Mongolia, China. Journal of the Science of Food and Agriculture 2008, 88, 2688-2692.
146. Miyoshi, S.; Ishikawa, H.; Kaneko, T.; Fukui, F.; Tanaka, H.; Maruyama, S. Structures and activity of angiotensin-converting enzyme inhibitors in an alpha-zein hydrolysate. Agricultural and Biological Chemistry 1991, 55, 1313-1318.
147. Sekiya, S.; Kobayashi, Y.; Kita, E.; Imamura, Y.; Toyama, S. Antihypertensive effects of tryptic hydrolysate of casein on normotensive and hypertensive volunteers. Journal of Japanese Society for Nutrition and Food Science 1992, 45, 513-517.
148. Yamamoto, N.; Maeno, M.; Takano, T. Purification and characterization of an antihypertensive peptides from a yogurt-like product fermented by Lactobacillus helvetius CPN4. Journal of Dairy Science 1999, 82, 1388-1393.
149. Cadée, J.A.; Chang, C.-Y.; Chen, C.-W.; Huang, C.-N.; Chen, S.-L.; Wang, C.-K. Bovine casein hydrolysate (C12 peptide) reduces blond pressure in prehypertensive subjects American Journal of Hypertension 2007, 20, 1-5.
150. Otte, J.; Shalaby, S.M.; Zakora, M.; Pripp, A.H.; EL-Shabrawy, S.A. Angiotensin-converting enzyme inhibitory activity of milk protein hydrolysates: effect of substrate, enzyme and time of hydrolysis. International Dairy Journal 2007, 17, 488-503.
151. Miguel, M.; Contreras, M.M.; Recio, I.; Aleixandre, A. ACE-inhibitory and antihypertensive properties of a bovine casein hydrolysate. Food Chemistry 2009, 112, 211-214.
152. van der Zander, K.; Bots, M.L.; Bak, A.A.A.; Koning, M.M.G.; De Leeuw, P.W. Enzymatically hydrolyzed lactotripeptides do not lower blood pressure in mildly hypertensive subjects. American Journal of Clinical Nutrition 2008, 88, 1697-1702.
153. Ponstein-Simarro Doorten, A.Y.; van de Wiel, J.A.G.; Jonker, D. Safety evaluation of an IPP tripeptide-containing milk protein hydrolysate. Food and Chemical Toxicology 2009, 47, 55-61.
154. Chabance, B.; Jollès, P.; Izquierdo, C.; Mazoyer, F.; Francoual, C.; Drouet, L.; Fiat, A.M. Characterization of an antithrombotic peptide from κ-casein in new born plasma after milk ingestion. British Journal of Nutrition 1995, 73, 583-590.
155. Cervato, G.; Cazzola, R.; Castaro, B. Studies on the antioxidant activity of milk caseins. International Journal of Food Science and Nutrition 1999, 50, 43-50.
156. Rival, S.G.; Fornaroli, S.; Boeriu, C.B.; Wichers, H.J. Caseins and casein hydrolysates. 1. Lipoxygenase inhibitory properties. Journal of Agricultural and Food Chemistry 2001, 49, 287-294.
157. FitzGerald, R.J.; Murray, B.A. Bioactive peptides and lactic fermentation. International Journal of Dairy Technology 2006, 59, 118-125.
158. Rossini, K.; Noreña, C.P.Z.; Cladera-Olivera, F.; Brandelli, A. Casein peptides with inhibitory activity on lipid oxidation in beef homogenates and mechanically deboned poultry meat. LWT-Food Science and Technology 2009, 42, 862-867.
159. Molina, P.E.; Abumrad, N.N. Metabolic effects of opiates and opioid peptides. Advances in Neuroimmunology 1994, 4, 105-116.
160. Meisel, H. Biochemical properties of peptides encrypted in bovine milk proteins. Current Medicinal Chemistry 2005, 12, 1905-1919.
161. Bouhallab, S.; Sapin, B.; Mollé, D.; Henry, G.; Léonil, J. Inhibition of bovine trypsin by the phosphorylated N-terminal part (1-105) of β-casein. Journal of Peptide Research 1997, 49, 23-27.
162. Sun, Z.; Zhang, Z.; Wang, X.; Cade, R.; Elmer, Z.; Fregly, M. Relation of beta-casomorphin to apnea in sudden infant death syndrome. Peptides 2003, 24, 937-943.
163. Asano, M.; Nio, N.; Ariyoshi, Y. Inhibition of prolyl endopeptidase by synthetic β-casein peptides and their derivatives with C-terminal prolinol or prolinal. Bioscience, Biotechnology and Biochemistry 1992, 56, 976-977.
164. Polgár, L.; Szeltner, Z. Structure, function and biological relevance of prolyl endopeptidase. Current Protein and Peptide Science 2008, 9, 96-107.
165. Juillerat-Jeanneret, L. Prolyl-specific peptidases and their inhibitors in biological processes. Current Chemical Biology 2008, 2, 97-109.
166. Cross, K.J.; Huq, N.L.; Palamara, J.E.; Perich, J.W.; Reynolds, E.C. Psysicochemical characterization of casein phosphopeptide-amorphous calcium phosphate nanocomplexes. Journal of Biological Chemistry 2005, 280, 15362-15369.
167. Adamson, N.J.; Reynolds, E.C. Characterization of tryptic casein phosphopeptides prepared under industrially relevant conditions. Biotechnology and Bioengineering 1995, 45, 196-204.
168. Perés, J.M.; Bouhallab, S.; Bureau, F.; Maubois, J.L.; Arhan, P.; Bougle, D. Absorption digestive du fer lie an caseinophosphopeptide 1-25 de la β-caseine. Lait 1997, 77, 433-440.
169. Hay, K.D.; Thomson, W.M. A clinical trial of the anticaries efficacy of casein derivatives complexed with calcium phosphate in patients with salivary gland dysfunction. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology 2002, 93, 271-275.
170. Pellegrini, A. Antimicrobial peptides from food proteins. Current Pharmaceutical Design 2003, 9, 1225-1238.
171. Lahov, E.; Regelson, A. Antibacterial and immunostimulating casein-derived substances from milk, casecidin, isracidin peptides. Food and Chemical Toxicology 1996, 34, 131-145.
172. s2 derived peptide exhibits antibacterial activity. FEBS Letters 1995, 372, 185-188.
173. s1-casein. Biochimica et Biophysica Acta 1999, 1428, 314-326.
174. Minervini, F.; Algaron, F.; Rizello, G.C.; Fox, P.F.; Monnet, V.; Gobbetti, M. Angiotensin I-converting-enzyme-inhibitory and antibacterial peptides from Lactobacillus helveticus PR4 proteinase-hydrolysed caseins of milk from six species. Applied and Environmental Microbiology 2003, 69, 5297-5305.
175. Birkemo, G.A.; O'Sullivan, O.; Ross, R.P.; Hill, C. Antimicrobial activity of two peptides casecidin 15 and 17, found naturally in bovine colostrum. Journal of AppliedMicrobiolology 2009, 106, 233-240.
176. Malkoski, M.; Dashper, S.G.; O'Brien-Simpson, N.M.; Talbo, G.H.; Maras, M.; Cross, K.J.; Reynolds, E.C. Kappacin, a novel antibacterial peptide from bovinemilk. Antimicrobial Agents and Chemotherapy 2001, 45, 2309-2315.
177. Hayes, M.; Barrett, E.; Ross, R.P.; Fitzgerald, G.F.; Hill, C.; Stanton, C. Evaluation of an antimicrobial ingredient prepared from a Lactobacillus acidophilus casein fermentate against Enterobacter sakazakii. Journal of Food Protection 2009, 72, 340-346.
178. Noursadeghi, M.; Bickerstaff, M.C.; Herbert, J.; Moyes, D.; Cohen, J.; Pepys, M.B. Production of granulocyte colony-stimulating factor in the nonspecific acute phase response enhances host resistance to bacterial infection. Journal of Immunology 2002, 169, 913-919.
179. Pereira, H.A. Novel therapies based on cationic antimicrobial peptides. Current Pharmaceutical Biotechnology 2006, 7, 229-234.
180. Migliore-Samour, D.; Floc'h, F.; Jollès, P. Biologically active casein peptides implicated in immunomodulation. Journal of Dairy Research 1989, 56, 357-362.
181. Hata, I.; Ueda, J.; Otani, H. Immunostimulatory action of a commercially available casein phosphopeptide preparation, CPP-III in cell cultures. Milchwissenschaft 1999, 54, 3-7.
182. Parker, F.; Migliore-Samour, D.; Floc'h, F. Immunostimulating hexapeptide from human casein: amino acid sequence, synthesis and biological properties. European Journal of Biochemistry 1984, 145, 677-682.
183. Yamada, K.; Matsumura, K.; Suzaki, M.; Shirahata, S.; Murakami, K. Stimulation and inhibition of interferon-β production of human diploid fibroblasts by foodstuffs. Agricultural and Biological Chemistry 1991, 55, 829-832.
184. Suder, P.; Kotlińska, J.; Smoluch, M.T.; Sällberg, M.; Silberring, J. Metabolic fate of nociceptin/orphanin FQ in the rat spinal cord and biological activity of its release fragment. Peptides 1999, 20, 239-247.
185. Otani, H.; Nakano, K.; Kawahara, T. Stimulatory effect of a dietary casein phosphopeptide preparation on the mucosal IgA response of mice to orally ingested lipopolysaccharide from Salmonella typhinurium. Bioscience Biotechnology and Biochemistry 2003, 67, 729-735.
186. Hermitte, L.; Atlan-Gepner, C.; Payan, M.J.; Mehelleb, M.; Vialettes, B. Dietary protection against diabetes in NOD mice: lack of a major change in the immune system. Diabete Metabolism 1995, 21, 261-268.
187. Wang, G.S.; Gruber, H.; Smyth, P.; Pulido, O.; Rosenberg, L.; Duguid, W.; Scott, F.W. Hydrolysed casein diet protects BB rats from developing diabetes by promoting islet neogenesis. Journal of Autoimmunity 2000, 15, 407-416.
188. Mullally, M.M.; Meisel, H.; FitzGerald, R.J. Identification of a novel angiotensin-I-converting enzyme inhibitory peptide corresponding to a tryptic fragment of bovine β-lactoglobulin. FEBS Letters 1997, 402, 99-101.
189. Shah, N. Effects of milk-derived bioactives: an overview. British Journal of Nutrition 2000, 84(Suppl. 1), S3-S10.
190. Maes, W.; Van Camp, J.; Vermeirssen, V.; Hemeryck, M.; Ketelslegers, J.M.; Schrezenmeir, J.; Van Oostveldt, P.; Huyghebaert, A. Influence of the lactokinin Ala-Leu-Pro-Met-His-Ile-Arg (ALPMHIR) on the release of endothelin-I by endothelial cells. Regulatory Peptides 2004, 118, 105-109.
191. Murakami, M.; Tonouchi, H.; Takahashi, R.; Kitazawa, H.; Kawai, Y.; Negishi, H.; Saito, T. Structural analysis of a new anti-hypertensive peptide (beta-lactosin B) isolated from a commercial whey product. Journal of Dairy Science 2004, 87, 1967-1974.
192. Bruck, W.M.; Kelleher, S.L.; Gibson, G.G.; Nielsen, K.E.; Chatterton, D.E.; Lönnerdal, B. rRNA probe used to quantify the effects of glycomacropeptide and alpha-lactalbumin supplementation on the predominant groups of intestinal bacteria of infant rhesus monkeys challenged with enteropathogenic Escherichia coli. Journal of Pediatriatrics, Gastroenterology and Nutrition 2003, 37, 273-280.
193. Fischer, W.; Gustafsson, L.; Mossberg, A.K.; Gronli, J.; Mork, S.; Bjerkvig, S.; Svanborg, C. Human alpha-lactalbumin made lethal to tumor cells (HAMLET) kills human glioblastoma cells in brain xenografts by an apoptosis-like mechanism and prolongs survival. Cancer Research 2004, 64, 2105-2112.
194. Fast, J.; Mossberg, A.K.; Svanborg, C.; Linse, S. Stability of HAMLET-A kinetically trapped α-lactalbumin oleic acid complex. Protein Science 2005, 14, 329-340.
195. Gustafsson, L.; Leijonhufvud, L.; Aronsson, A.; Mossberg, A.K.; Svanborg, C. Treatment of skin papillomas with typical alpha-lactalbumin-oleic acid. New England Journal of Medicine 2004, 350, 2663-2672.
196. Aits, S.; Gustafsson, L.; Hallgren, O.; Brest, P.; Gustafsson, M.; Trulsson, M.; Mossberg, A.K.; Simon, H.-U.; Morgrabi, B.; Svanborg, C. HAMLET (human α-lactalbumin made lethal to tumor cells) triggers autophagic tumor cell death. International Journal of Cancer 2009, 124, 1008-1019.
197. Knyazeva, E.L.; Grishchenko, V.M., Fadeev R.S., Akatov V.S., Permyakov S.E., Permyakov E.A. Who is Mr HAMLET? Interaction of human α-lactalbumin with monomeric oleic acid. Biochemistry 2008, 47, 13127-13137.
198. Kamijima, T.; Ohmura, A.; Sato, T.; Akimoto, K.; Itabashi, M.; Mizuguchi, M.; Kamiya, M.; Kikukawa, T.; Aizawa, T.; Takahashi, M.; Kawano, K.; Demura, M. Heat-treatment method for producing fatty acid-bound alpha-lactalbumin that induces tumor cell death. Biochemical and Biophysical Research Communications 2008, 376, 211-214.
199. Pihlanto-Leppälä, A. Bioactive peptides derived from bovine whey proteins: opioid and ACEinhibitory peptides. Trends in Food Science and Technology 2001, 11, 347-356.
200. Markus, C.R.; Olivier, B.; Panhuysen, G.E.; Van Der Gugten, J.; Alles, M.S.; Tuiten, A.; Westenberg, H.G.; Fekkes, D.; Koppeschaar, H.F.; de Haan, E.E. The bovine protein alphalactalbumin increases the plasma ratio of tryptophan to the other large neutral amino acids, and in vulnerable subjects raises brain serotonin activity, reduces cortisol concentration, and improves mood under stress. American Journal of Clinical Nutrition 2000, 71, 1536-1544.
201. Orosco, M.; Rouch, C.; Beslot, F.; Feurte, S.; Regnault, A.; Dauge, V. Alpha-lactalbuminenriched diets enhance serotonin release and induce anxiolytic and rewarding effects in the rat. Behavior and Brain Research 2004, 48, 1-10.
202. Ng, T.B.; Lam, T.L.; Au, T.K.; Ye, X.Y.; Wan, C.C. Inhibition of human immunodeficiency virus type 1 reverse transcriptase, protease and integrase by bovine milk proteins. Life Sciences 2001, 69, 2217-2223.
203. Farnfield, M.M.; Smith, S.; Stockmann, R. Antioxidant activity of β-lactoglobulin and its modified derivatives. Australian Journal of Dairy Technology 2003, 58, 186-192.
204. Nagaoka, S.; Futamura, Y.; Miwa, K.; Awano, K.; Yamauchi, K.; Kanamaru, Y. Identification of novel hypocholesterolemic peptides derived from bovine milk β-lactoglobulin. Biochemical and Biophysical Research Communications 2001, 281, 11-17.
205. Baker, E.N.; Baker, H.M. A structural framework for understanding the multifunctional character of lactoferrin. Biochimie 2009, 91, 3-10.
206. Flanagan, J.L.; Willcox, M.D.P. Role of lactoferrin in the tear film. Biochimie 2009, 91, 35-43.
207. Jenssen, H.; Hancock, R.E.W. Antimicrobial properties of lactoferrin. Biochimie 2009, 91, 19-29.
208. Ochoa, T.J.; Cleary, T.G. Effect of lactoferrin on enteric pathogens. Biochimie 2009, 91, 30-34.
209. Paesano, R.; Pietropaoli, M.; Gessani, S.; Valenti, P. The influence of lactoferrin, orally administered, on systemic iron homeostasis in pregnant women suffering of iron deficiency and iron deficiency anaemia. Biochimie 2009, 91, 44-51.
210. Puddu, P.; Valenti, P.; Gessani, S. Immunomodulatory effects of lactoferrin on antigen presenting cells. Biochimie 2009, 91, 11-18.
211. Tomita, M.; Wakabayashi, H.; Shin, K.; Yamauchi, K.; Yaeshima, T.; Iwatsuki, K. Twenty-five years of research on bovine lactoferrin applications. Biochimie 2009, 91, 52-57.
212. Vogel, H.J.; Schibli, D.J.; Weiguo, J.; Lohmeier-Vogel, E.M.; Epand, R.F.; Epand, R.M. Towards a structure-function analysis of bovine lactoferricin and related tryptophan and arginine containing peptides. Biochemistry and Cell Biology 2002, 80, 49-63.
213. Rekdal, Ø.; Andersen, J.; Vorland, L.H.; Svendsen, J.S. Construction and synthesis of lactoferricin derivatives with enhanced antibacterial activity. Journal of Peptide Science 1999, 5, 32-45.
214. Tomita, M.; Wakabayashi, H.; Yamauchi, K.; Teraguchi, S.; Hayasawa, H. Bovine lactoferrin and lactoferricin derived from milk: production and applications. Biochemistry and Cell Biology 2002, 80, 109-112.
215. Bellamy, W.; Takase, M.; Yamauchi, K.; Wakabayashi, H.; Kawase, K.; Tomita, M. Identification of the bactericidal domain of lactoferrin. Biochimica et Biophysica Acta 1992, 1121, 130-136.
216. Van der Kraan, M.I.A.; Groenink, J.; Nazmi, K.; Veerman, E.C.; Bolscher, J.G.M.; Nieuw Amerongen, A.V. Lactoferrampin-novel antimicrobial peptide in the N1-domain of bovine lactoferrin. Peptides 2004, 25, 177-183.
217. Bolscher, J.G.M.; van der Kraan, M.I.A.; Nazmi, K.; Kalay, H.; Gru{double acute}n, C.H.; van't Hof, W.; Veerman, E.C.I.; Nieuw Amerongen, A.V. A one-enzyme strategy to release an antimicrobial peptide from the Lfampin-domain of bovine lactoferrin. Peptides 2006, 27, 1-9.
218. Bolscher, J.G.M.; Adão, R.; Nazmi, K.; van den Keybus, P.A.M.; van't Hof, W.; Nieuw Amerongen, A.V.; Bastos, M.; Veerman, E.C.I. Bactericidal activity of LFchimera is stronger and less sensitive to ionic strength than its constituent lactoferricin and lactoferrampin peptides. Biochimie 2009, 91, 123-132.
219. Leon-Sicairos, N.; Canizalez-Roman, A.; de la Garza, M.; Reyes-Lopez, M.; Zazueta-Beltran, J.; Nazmi, K.; Gomez-Gil, B.; Bolscher, J.G.M. Bactericidal effect of lactoferrin and lactoferrin chimera against halophilic Vibrio parahaemolyticus. Biochimie 2009, 91, 133-140.
220. Haney, E.F., Nazmi, K.; Lau, F.; Bolscher, J.G.M.; Vogel, H.J. Novel lactoferrampin antimicrobial peptides derived from human lactoferrin. Biochimie 2009, 91, 141-154.
221. Weinberg, E.D. Iron, infection, and neoplasia. Clinical Physiology and Biochemistry 1986, 4, 50-60.
222. Ellison, R.T.; Giehl, T.J. Killing of gram-negative bacteria by lactoferrin and lysozyme. Journal of Clinical Investigation 1991, 88, 1088-1091.
223. Diarra, M.S.; Petitclerc, D.; Lacasse, P. Effect of lactoferrin in combination with penicilin on the morphology and physiology of Staphylococcus aureus isolated from bovine mastitis. Journal of Dairy Science 2002, 85, 1141-1149.
224. van der Strate, B.W.; Beljaars, L.; Molema, L.G.; Harmsen, M.C.; Meijer, D.K. Antiviral activities of lactoferrin. Antiviral Research 2001, 52, 225-239.
225. Marr, A.K.; Jenssen, H.; Roshan Moriri, M.; Hancock, R.E.W.; Panté, N. Bovine lactoferrin and lactoferricin interfere with intracellular trafficking of Herpes simplex virus-1. Biochimie 2009, 91, 160-164.
226. Li, S.; Zhou, H.; Huang, G.; Liu, N. Inhibition of HBV infection by bovine lactoferrin and iron-, zinc-saturated lactoferrin. Medical Microbiology and Immunology 2009, 198, 19-25.
227. Rodrigues, L.; Teixeira, J.; Schmitt, F.; Paulsson, M.; Månsson, H.L. Lactoferrin and cancer disease prevention. Critical Reviews in Food Science and Nutrition 2009, 49, 203-217.
228. Eliassen, L.T.; Berge, G.; Sveinbjornsson, J.S.; Vorland, L.H.; Rekdal, Ø. Evidence for a direct antitumor mechanism of action of bovine lactoferricin. Anticancer Research 2002, 22, 2703-2710.
229. Shimamura, M.; Yamamoto, Y.; Ashino, H.; Oikawa, T.; Hazato, T.; Tsuda, H.; Iigo, M. Bovine lactoferrin inhibits tumor-induced angiogenesis. International Journal of Cancer 2004, 111, 111-116.
230. Weinberg, E.D. The role of iron in cancer. European Journal of Cancer Prevention 1996, 5, 19-36.
231. Onishi, J.; Roy, M.K.; Juneja, L.R.; Watanabe, Y.; Tamai, Y. A lactoferrin-derived peptide with cationic residues concentrated in a region of its helical structure induces necrotic cell death in a leukemic cell line (HL-60). Journal of Peptide Science 2008, 14, 1032-1038.
232. Hayes, T.G.; Falchook, G.F.; Varadhachary, G.R.; Smith, D.P.; Davis, L.D.; Dhingra, H.M.; Hayes, B.P.; Varadhachary, A. Phase I trial of oral lactoferrin alfa in refractory solid tumors. Investigation on New Drugs 2006, 24, 233-240.
233. Iigo, M.; Alexander, D.B.; Long, N.; Xu, J.; Fukamachi, K.; Futakuchi, M.; Takase, M.; Truda, H. Anticarcinogenesis pathways activated by bovine lactoferrin in the murine small intestine. Biochimie 2009, 91, 86-101.
234. Mariller, C.; Hardivillé, S.; Hoedt, E.; Benaïssa, M.; Mazurier, J.; Pierce, A. Proteomic approach to the identification of novel delta-lactoferrin target genes: characterization of DcpS, an mRNA scavenger decapping enzyme. Biochimie 2009, 91, 109-122.
235. Lee, S.-H.; Park, S.W.; Pyo, C.-W.; Yoo, N.-K.; Kim, J.; Choi, S.-Y. Requirement of the JNKassociated Bcl-2 pathway for human lactoferrin-induced apoptosis in the Jurkat leukemia T cell line. Biochimie 2009, 91, 102-108.
236. Raha, S.; Dosquet, C.; Abgrall, J.F.; Jollès, P.; Fiat, A.-M.; Caen, J.P. KRDS-a tetrapeptide derived from lactoferrin inhibits binding of monoclonal antibodies against glycoprotein IIb-IIIa on ADP stimulated platelets and megakaryocytes. Blood 1988, 72, 172-178.
237. Bournazou, I.; Pound, J.D.; Duffin, R.; Bournazos, S.; Melville, L.A.; Brown, S.B.; Rossi, A.G.; Gregory, C.D. Apoptotic human cells inhibit migration of granulocytes via release of lactoferrin. The Journal of Clinical Investigation 2009, 119, 20-32.
238. Troost, F.J.; Saris, W.H.M.; Brummer, R.-J.M. Recombinant human lactoferrin ingestion attenuates indomethacin-induced enteropathy in vivo in healthy volunteers. European Journal of Clinical Nutrition 2003, 57, 1579-1585.
239. Sfeir, R.M.; Dubarry, M.; Boyaka, P.N.; Rautureau, M.; Tomé, D. The mode of oral bovine lactoferrin administration influences mucosal and systemic immune responces in mice. Journal of Nutrition 2004, 134, 403-439.
240. Shimizu, H. Development of an enteric-coated lactoferrin tablet and its application, Biometals 2004, 17, 343-347.
241. Masschalck, B.; Michiels, C.W. Antimicrobial properties of lysozyme in relation to foodborne vegetative bacteria. Critical Reviews in Microbiology 2003, 29, 191-214.
242. Edde, L.; Hipolito, R.B.; Hwang, H.F.; Headon, D.R.; Shalwitz, R.A.; Herman, M.P. Lactoferrin protects neonatal rats from gut-related systemic infection. American Journal of Physiology, Gastrointestinal and Liver Physiology 2001, 281, G1140-G1150.
243. Bol'shakova, A.M.; Shcherbakova, E.G.; Ivanova, S.D.; Medvedeva M.M.; Zhuravleva, T.P. Lysozyme and the feeding of premature infants with mixed pathology. Antibiotiki 1984, 29, 784-790.
244. Ogundele, M.O. A novel anti-inflammatory activity of lysozyme: modulation of serum complement activation. Mediators of Inflammation 1998, 7, 363-365.
245. Bianchi, C. Is Fleming's lysozyme an analgesic agent? An experimental reappraisal of clinical data. European Journal of Pharmacology 1981, 71, 211-221.
246. Ibrahim, H.R.; Matsuzaki, T.; Aoki, T. Genetic evidence that antibacterial activity of lysozyme is independent of its catalytic function. FEBS Letters 2001, 506, 27-32.
247. Shin, K.; Yamauchi, K.; Teraguchi, S.; Hayasawa, H.; Imoto, I. Susceptibility of Heliobacter pylori and its urease activity to the peroxidase-hydrogen peroxide-thiocyanate antimicrobial system. Journal of Medical Microbiolology 2002, 51, 231-237.
248. Wray, C.; McLaren, I. A note on the effect of the lactoperoxidase systems on salmonellas in vitro and in vivo. Journal of Applied Bacteriology 1987, 62, 115-118.
249. van Hooijdonk, A.C.; Kussendrager, K.D.; Steijns, J.M. In vivo antimicrobial and antiviral activity of components in bovine milk and colostrum involved in non-specific defence. British Journal of Nutrition 2000, 84, S127-S134.
250. Arqués, J.L.; Rodríguez, E.; Nuñez, M.; Medina, M. Antimicrobial activity of nisin, reuterin and the lactoperoxidase system on Listeria monocytogenes and Stapylococcus aureus in cuajada, a semisolid dairy product manufactured in Spain. Journal of Dairy Science 2008, 91, 70-75.
251. Yener, F.Y.G.; Korel, F.; Yemeniciǒglu, A. Antimicrobial activity of lactoperoxidase system incorporated into cross-linked alginate films. Journal of Food Science 2009, 74, M73-M79.
252. Matsushita, A., Son, D.O.; Satsu, H.; Takano, Y.; Kawakami, H.; Totsuka, M. Inhibitory effect of lactoperoxidase on the the secretion of proinflammatory cytokine interlukin-8 in human intestinal epithelial Caco-2 cells. International Dairy Journal 2008, 18, 932-938.
253. Shin, K.; Horigome, A.; Yamauchi, K.; Takase, M.; Yaeshima, T.; Iwatsuki, K. Effects of orally administered bovine lactoperoxidase on dextran sulfate sodium-induced colitis in mice. Bioscience, Biotechnology and Biochemistry 2008, 72, 1932-1935.
254. Abd El-Salam, M.H.; El-Shibiny, S.; Buchheim, W. Characteristics and potential uses of the casein macropeptide. International Dairy Journal 1996, 6, 327-341.
255. Neeser, J.R.; Chambaz, A.; Del Vedovo, S.; Prigent, M.J.; Guggenheim, B. Specific and nonspecific inhibition of adhesion of oral actinomyces and streptococci to erythrocytes and polystyreneby caseinoglycopeptide derivatives. Infection and Immunity 1988, 56, 3201-3208.
256. Neeser, J.R. Dental anti-plaque and anti-caries agent. U.S. Patent No. 4,992,420, 1991.
257. Dziuba, J.; Minkiewicz, P. Influence of glycosylation on micelle-stabilizing ability and biological properties of C-terminal fragments of cow's κ-casein. International Dairy Journal 1996, 6, 1017-1044.
258. Silva-Hernandez, E.R.; Nakano, T.; Ozimek, L. Isolation and analysis of kappa-casein glycomacropeptide from goat sweet whey. Journal of Agricultural and Food Chemistry 2002, 50, 2034-2038.
259. Kawasaki, Y.; Isoda, H.; Tanimoto, M.; Dosako, S.; Idota, T.; Ahiko, K. Inhibition by lactoferrin and κ-casein glycomacropeptide of binding of cholera toxin to its receptor. Bioscience Biotechnology and Biochemistry 1992, 56, 195-198.
260. Isoda, H.; Kawasaki, Y.; Tanimoto, M.; Dosako, S.; Idota, T. Use of compounds containing or binding sialic acid to neutralize bacterial toxins. European Patent No. 385112, 1999.
261. Dashper, S.G.; Liu, S.W.; Reynolds, E.C. Antimicrobial peptides and their potential as oral therapeutic agents. International Journal of Peptide Research and Therapeutics 2007, 13, 505-516.
262. Idota, T.; Kawakami, H.; Nakajima, I. Bifidus growth promoting effect of N-acetylneuraminic acid-containing substances. Bioscience Biotechnology Biochemistry 1994, 58, 1720-1722.
263. Bal Dit Soullier, C.; Drouet, L.; Pignaud, G.; Chevallier, C.; Caen, J.; Fiat, A.-M.; Izquierdo, C.; Jollès, P. Effect of kappa-casein split peptides on platelet aggregation and on thrombus formation in the guinea-pig. Thrombosis Research 1996, 81, 427-437.
264. Stan, E.Y.; Ekimovskii, A.P.; Aleinik, S.I.; Zhuravlev, B.V. Heterogeneity and physiological activity of bovine κ-casein proteolysis products. Voprosy Pitanija 1988, 1, 39-43.
265. Kelleher, S.L.; Chatterton, D.; Nielsen, K.; Lönnerdal, B. Glycomacropeptide and α-lactalbumin supplementation of infant formula affects growth and nutritional status in infant rhesus monkeys. American Journal of Clinical Nutrition 2003, 77, 1261-1268.
266. Guilloteau, P.; Le Hüerou-Luron, I.; Chayvialle, J.A.; Legeas, M.; Bernard, C.; Roger, L.; Mendy, F. Effect of caseinomacropeptide (CMP) on gastric secretion and gut regulatory peptides in preruminant calves. Reproduction Nutrition and Development 1994, 34, 612-613.
267. Royle, P.J.; McIntosh, G.H.; Clifton, P.M. Whey protein isolate and glycomacropeptide decrease weight gain and alter body composition in male Wistar rats. British Journal of Nutrition 2008, 100, 88-93.
268. Ramachandran, G.N.; Sasisekharan, V. Conformation of polypeptides and proteins. Advances in Protein Chemistry 1968, 23, 283-437.
269. Zhang, L.; Parente, J.; Harris, S.M.; Woods, D.E.; Hancock, R.E.W.; Falla, T.J. Antimicrobial peptide therapeutics for cystic fibrosis. Antimicrobial Agents and Chemotheraphy 2005, 49, 2921-2927.
270. Barrett, C.T.; Barrett, J.F. Antibacterials: are the new entries enough to deal with the emerging resistance problems? Current Opinion in Biotechnology 2003, 14, 621-626.
271. Janusz, M.; Lisowski, J.; Franek, F. Isolation and characterization of a proline-rich polypeptide from ovine colostrums. FEBS Letters 1974, 49, 276-279.
272. Kruzel, M.L.; Polanowski, A.; Wilusz, T.; Sokołowska, A.; Pacewicz, M.; Bednarz, R.; Georgiades, J.A. The alkohol-induced conformational changes in casein micelles: a new challenge for the purification of colostrinin. Protein Journal 2004, 23, 127-133.
273. Sokołowska, A.; Bednarz, R.; Pacewicz, M.; Georgiades, J.A.; Wilusz, T.; Polanowski, A. Colostrum from different mammalian species-a rich source of colostrinin. International Dairy Journal 2008, 18, 204-209.
274. Janusz, M.; Woszczyna, M.; Lisowski, M.; Kubis, A.; Macała, J.; Gotszalk, T.; Lisowski, J. Ovine colostrum nanopeptide affects amyloid beta aggregation. FEBS Letters 2009, 583, 190-196.
275. Popik, P.; Bobula, B.; Janusz, M.; Lisowski, J.; Vetulani, J. Colostrinin, a polypeptide isolated from early milk, facilitates learning and memory in rats. Pharmacology and Biochemistry of Behaviour 1999, 64, 183-189.
276. Boldogh, I.; Aguilera-Aguirre, L.; Bacsi, A.; Choudhury, B.K.; Saavedra-Molina, A.; Kruzel, M. Colostrinin decreases hypersensitivity and allergic responses to common allergens. International Archives of Allergy and Immunology 2008, 146, 298-306.
277. Szaniszlo, P.; German, P.; Hajas, G.; Saenz, D.N.; Woodberry, M.W.; Kruzel, M.L.; Boldogh, I. Effects of colostrinin™ on gene expression-transcriptomal network analysis. International Immunopharmacology 2009, 9, 181-193.
278. Abe, H.; Saito, H.; Miyakawa, H.; Tamura, Y.; Shimamura, S.; Nagao, E.; Tomita, M. Heat stability of bovine lactoferrin at acidic pH. Journal of Dairy Science 1991, 74, 65-71.
279. Ikeda, M.; Nozaki, A.; Sugiyama, K.; Tanaka, T.; Naganuma, A.; Tanaka, A.; Sekihara, H.; Shimotohno, K.; Saito, M.; Kato, N. Characterization of antiviral activity of lactoferrin against Hepatitis soda wirus infection in human cultured cells. Virus Research 2000, 66, 51-63.